Business Context and Reporting Period
This Form 8-K filing by Neuronetics, Inc. (STIM) is dated October 4, 2024. The report addresses a regulatory notice received on October 3, 2024, regarding the company's compliance with Nasdaq listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the status of the company's stock listing.
Material Changes
The primary material event is the receipt of a deficiency letter from the Nasdaq Listing Qualifications Department. The letter states that for the last 30 consecutive business days, the closing bid price of the company's common stock has been below the minimum $1.00 per share required under Nasdaq Listing Rule 5450(a)(1).
Outlook, Risks, and Management Commentary
- Compliance Period: The company has been granted 180 calendar days, until April 1, 2025, to regain compliance.
- Compliance Criteria: To achieve compliance, the stock must close at $1.00 per share or more for a minimum of 10 consecutive business days before the deadline.
- Secondary Compliance Option: If the company fails to comply by April 1, 2025, it may be afforded a second 180-day period, contingent upon transferring to The Nasdaq Capital Market and meeting its initial listing standards (excluding the bid price requirement).
- Delisting Risk: Failure to regain compliance by the end of the applicable period will result in delisting. The company retains the right to appeal a delisting determination.
- Management Action: Management intends to monitor the stock price and may consider a reverse stock split to regain compliance, though there is no assurance of success.
Investor Verification Checklist
- Verify the current closing bid price of STIM stock relative to the $1.00 threshold.
- Monitor the company's announcements regarding the potential implementation of a reverse stock split.
- Track the stock's performance to ensure it meets the 10 consecutive business day requirement before April 1, 2025.
- Review future filings for any updates on the transfer to The Nasdaq Capital Market if the initial compliance period expires.